We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use www.guysandstthomasevents.co.uk, remember your settings and improve our services. We also use cookies set by other sites to help us deliver content from their services.
This programme provides an up-to-date, expert overview of the 2025 diagnostic and therapeutic landscape of cutaneous and systemic mastocytosis, highlighting current management pathways and emerging targeted treatments
A focused update on the 2025 landscape of mastocytosis, covering current advances in the diagnosis and management of both cutaneous and systemic forms.
Course aims
To enhance clinical expertise in recognising and treating mastocytosis – from cutaneous disease and anaphylaxis to non-advanced and advanced systemic mastocytosis – highlighting contemporary diagnostic approaches and the evolving role of tyrosine kinase inhibitors in trials and clinical practice.
Who should attend
This event is suitable for senior registrars, specialist nurses, consultants across the specialties involved in care of patients, dermatologists, immunologists, allergists, hematopathologists and haematologists.
